DP VII Associates L.P., 10% Owner at Orexigen Therapeutics, Inc. (OREX), bought 231 shares at $7.73 ($2K) on 2009-08-18, disclosed to the SEC on 2009-08-19.
Open-market purchase of $2k OREX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| EVOK | SELL | 2016-04-21 | $4K | — | Filing → |
| EVOK | SELL | 2016-04-08 | $5K | — | Filing → |
| ESPR | BUY | 2013-07-02 | $67K | — | Filing → |